logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
F

Francesco Passamonti

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

90H指数
700论文数
3.9W被引数
收录论文 194
发表时间
logo
Role of direct-acting antivirals in people with HIV-associated non-Hodgkin lymphoma and concomitant HCV infection: A study on behalf of the Fondazione Italiana Linfomi直接抗病毒药物在合并HCV感染的HIV相关非霍奇金淋巴瘤患者中的作用：意大利淋巴瘤基金会研究
errBritish Journal of Haematology
IF3.8
err2026-09-06
err0
PREAI
errMichele Merli; Benedetta Bianchi; Michele Bibas; Davide Dalu; Rosa Daffini; Emanuele Ravano; Giovanni Rindone; Guido Gini; Carlo Visco; Maria Chiara Tisi; Emanuele Cencini; Dario Marino; Massimo Gentile; Valentina Zuccaro; Cristina Rovelli; Valentina Mazzotta; Cinzia Fasola; Vittorio Ruggero Zilioli; Luisa Verga; Carmela Pinnetti; Manuel Gotti; Francesca Gaia Rossi; Nicolò Rampi; Andrea Ferrario; Chiara Pagani; Layla Pagnucco; Nicla La Verde; Paolo Grossi; Alessandra Bandera; Luigi Marcheselli; Marta Coscia; Francesco Passamonti; Michele Spina; Luca Arcaini; Alessandro Re
err分享
err收藏
Adding transcriptomic features to MF prognostic models将转录组特征添加到MF预后模型中
errBlood
IF23.1
err2026-05-07
err0
PREAI
errFrancesco Passamonti
err分享
err收藏
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study赖氨酸特异性去甲基化酶1（LSD1）抑制剂bomedemstat在骨髓纤维化中的应用：一项1/2期研究的结果
errBlood Advances
IF7.1
err2026-05-02
err0
errOAAI
errHarinder Gill; Abdulraheem Yacoub; Aaron T. Gerds; Jake Shortt; James M. Rossetti; Adam J. Mead; Joachim R Göthert; Steffen Koschmieder; Joanne Ewing; Anna Halpern; Francesca Palandri; Francesco Passamonti; Ruben Mesa; Monia Marchetti; Claire Harrison; Alessandro M. Vannucchi; Justin M. Watts; John C. Wood; David M. Ross; Jennifer Peppe
err分享
err收藏
Identification of ceRNA Regulatory Networks Driven by the lncRNA NEAT1 in Multiple MyelomalncRNA NEAT1驱动的多发性骨髓瘤中ceRNA调控网络的鉴定
errJournal of Cellular and Molecular Medicine
IF4.2
err2026-04-02
err0
errOAAI
errDomenica Ronchetti; Valentina Traini; Ilaria Silvestris; Giuseppina Fabbiano; Andrea Devecchi; Federica Torricelli; Noemi Puccio; Ilaria Craparotta; Marco Bolis; Roberto Piva; Antonino Neri; Luca Agnelli; Francesco Passamonti; Niccolò Bolli; Elisa Taiana
err分享
err收藏
Health Care Utilization Databases obtained from health system inform outcome for ruxolitinib treatment in patients with myelofibrosis来自卫生系统信息的数据库显示，ruxolitinib治疗对骨髓纤维化患者的影响结果。
errHemaSphere
IF14.6
err2026-02-24
err0
errOAAI
errBarbara Mora; Matteo Franchi; Ludovica Margotto; Olivia Leoni; Daniela D'ippoliti; Emanuela Carloni; Ilaria Cozzi; Enrica Santelli; Fabrizio Gemmi; Claudia Szasz; Margherita Maffioli; Carmelo Gurnari; Enrico Attardi; Daniele Cattaneo; Marta Bortolotti; Nicola Stefano Fracchiolla; Alessandra Iurlo; Giovanni Corrao; Matteo Giovanni Della Porta; Alessandro Maria Vannucchi; Maria Teresa Voso; Paola Guglielmelli; Francesco Passamonti
err分享
err收藏
Characterization of a Newly Discovered Non-Coding Variant in the EPO Gene Identified in Two Unrelated Italian Pedigrees With Erythrocytosis新发现的EPO基因中非编码变异在两个无关意大利家系中红细胞增多症中的表征
errAmerican Journal of Hematology
IF9.9
err2026-02-18
err0
errOAAI
errBarbara Mora; Valentina Bellani; Daniela Pietra; Elena Tagliaferri; Daniele Cattaneo; Oscar Borsani; Alessandra Iurlo; Elisa Fermo; Paola Bianchi; Elisa Rumi; Francesco Passamonti
err分享
err收藏
Atypical chronic myeloid leukemia: From diagnosis to molecular features and therapeutic options非典型慢性髓性白血病：从诊断到分子特征和治疗选择
errHEMASPHERE
IF14.6
err2025-12-09
err0
errOAAI
errIurlo, Alessandra; Cattaneo, Daniele; Gianelli, Umberto; Passamonti, Francesco
err分享
err收藏
Predicting the differential diagnosis of inherited versus acquired bone marrow failure syndromes: Development of simple clinical scoring systems
errBRITISH JOURNAL OF HAEMATOLOGY
IF3.8
err2025-12-01
err0
PREAI
errBortolotti, Marta; Fattizzo, Bruno; Stella, Simona; Jiang, Jie; Versino, Francesco; Engelbrecht, Clair; Trikha, Roochi; Large, Joanna; Gandhi, Shreyans; Snape, Katie; Consonni, Dario; Passamonti, Francesco; Barcellini, Wilma; Kulasekararaj, Austin G.
err分享
err收藏
European LeukemiaNet criteria for safety and efficacy evaluation of new drugs for myelofibrosis欧洲白血病网络联盟（European LeukemiaNet）关于新药在骨髓纤维化中安全性和有效性评估的标准
errBlood Cancer Journal
IF11.6
err2025-11-24
err0
errOAAI
errMonia Marchetti; Alessandro Maria Vannucchi; John O. Mascarenhas; Alberto Alvarez-Larran; Prithviraj Bose; Robert Peter Gale; Claire Harrison; Rűdiger Hehlmann; Jean-Jacques Kiladjian; Steffen Koschmieder; Ruben Mesa; Francesco Passamonti; Alessandro Rambaldi; Ayalew Tefferi; Tiziano Barbui
err分享
err收藏
Effect of obexelimab on the production of anti-RBC antibodies and cytokines in patients with warm autoimmune hemolytic anemia
errBlood Advances
IF7.1
err2025-10-10
err0
errOAAI
errBruno Fattizzo; Anna Zaninoni; Giacinto Luca Pedone; Marta Bortolotti; Francesco Passamonti; Wilma Barcellini
err分享
err收藏
Viral respiratory infections in patients with hematological diseases over 10 years: epidemiology and impact on disease severity10年来血液病患者的病毒性呼吸道感染：流行病学及其对疾病严重程度的影响
errDIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
IF1.8
err2025-10-01
err0
PREAI
errBono, Patrizia; Parisi, Alessandra; Tagliaferri, Elena; Ungaro, Riccardo; Saporiti, Gorgia; Cavallaro, Francesca; Bozzi, Giorgio; Goldaniga, Maria Cecilia; Galli, Gianluigi; Hejazifar, Niloofar; Allaria, Silvia; Biassoni, Caterina; Giacomel, Giovanni; Valzano, Antonia; Sciume, Mariarita; Fracchiolla, Nicola; Bandera, Alessandra; Passamonti, Francesco; Callegaro, Annapaola; Alteri, Claudia
err分享
err收藏
Treatment persistence and overall survival in myelofibrosis treated with ruxolitinib were not affected by the covid-19 pandemic, despite the reduced starting dose: Analysis of AIFA registries尽管起始剂量有所减少，接受鲁索利替尼治疗的骨髓纤维化患者的治疗持续性和总生存期并未受到COVID-19大流行的影响：意大利药品管理局登记数据分析
errAnnals of Hematology
IF2.4
err2025-09-20
err0
errOAAI
errMassimo Breccia; Simone Celant; Francesca Palandri; Francesco Passamonti; Pier Paolo Olimpieri; Valentina Summa; Annalisa Guarcello; Giuseppe Alberto Palumbo; Fabrizio Pane; Paola Guglielmelli; Pierluigi Zinzani; Paolo Corradini; Pierluigi Russo
err分享
err收藏
Bone marrow microenvironment in autoimmune hemolytic anemia: from trephine biopsy to single cell RNA sequencing自身免疫性溶血性贫血的骨髓微环境：从锥形活检到单细胞RNA测序
errSignal Transduction and Targeted Therapy
IF52.7
err2025-08-25
err0
errOAAI
errBruno Fattizzo; Matteo Claudio Da Vià; Francesca Lazzaroni; Alfredo Marchetti; Alessio Marella; Akihiro Maeda; Antonio Giovanni Solimando; Loredana Pettine; Francesco Passamonti; Niccolò Bolli; Wilma Barcellini
err分享
err收藏
Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter Experience阵发性夜间血红蛋白尿症患者突破性溶血的特征：一项国际多中心经验
errAmerican Journal of Hematology
IF9.9
err2025-08-11
err0
errOAAI
errBruno Fattizzo; Giacinto Luca Pedone; Elisabetta Metafuni; Eloise Beggiato; Valentina Giai; Esther Natalie Oliva; Antony Ricchiuti; Marta Bortolotti; Simona Raso; Daniela Carlino; Mara Memoli; Sofia Vecchi; Jennifer Vidler; Sukanya Gogoi; Shreya Goel; Anna Corby; Roochi Trikha; Sneha Balakrishnan; Francesco Passamonti; Anna Paola Iori; Simona Sica; Shreyans Gandhi; Wilma Barcellini; Austin Kulasekararaj
err分享
err收藏
Exploring thromboembolic risk factors in polycythemia vera: from current evidence to PROSPERO study design探讨真性红细胞增多症的血栓栓塞危险因素：从现有证据到PROSPERO研究设计
errAnnals of Hematology
IF2.4
err2025-07-18
err0
errOAAI
errValerio De Stefano; Francesco Passamonti; Francesca Palandri; Francesco Ramundo; Elena Rossi; Silvia Betti; Lorenzo Fagiolo; Paola Guglielmelli; Davide Pio Abagnale; Novella Pugliese; Daniele Cattaneo; Alessandra Iurlo; Filippo Branzanti; Alessandra Dedola; Hillary Catellani; Alessia Tieghi; Marco Basso; Elisabetta Calistri; Elena Maria Elli; Elena Masselli; Erika Morsia; Giulia Benevolo; Massimo Breccia; Vincenza de Fazio; Maria Di Perna; Monia Marchetti; Marco Santoro; Agostino Tafuri; Chiara Castiglioni; Chiara Rotella; Sergio Siragusa; Alessandro Maria Vannucchi
err分享
err收藏
Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-Switch study真性红细胞增多症高风险患者在接受一线治疗效果不佳后切换至鲁索利替尼治疗与非切换者的临床结局比较：PV-Switch研究的结果
errTherapeutic Advances in Hematology
IF3.1
err2025-07-04
err0
errOAAI
errSteffen Koschmieder; Clemens Schulte; Eyck von der Heyde; Lambert Busque; Françoise Boyer-Perrard; Timothy Devos; Francesco Passamonti; Wendy Y. Cheng; Mu Cheng; Marja Nuortti; Volker Baum; Claire Harrison
err分享
err收藏
Rituximab efficacy for minimal residual disease eradication in philadelphia-negative acute lymphoblastic leukemia CD20+利妥昔单抗对费城染色体阴性急性淋巴细胞白血病CD20+患者微小残留病的清除效果
errANNALS OF HEMATOLOGY
IF2.4
err2025-05-16
err0
errOAAI
errCecchi, Nicola; Sciume, Mariarita; Ricchiuti, Antony; Bosi, Alessandro; Tagliaferri, Elena; Passamonti, Francesco; Fracchiolla, Nicola Stefano
err分享
err收藏
BLAST: a globally applicable and molecularly versatile survival model for chronic myelomonocytic leukemiaBLAST：一种适用于全球范围且分子上具有多样性的慢性髓系单核细胞白血病患者生存模型
errBlood
IF23.1
err2025-05-09
err0
PREAI
errAyalew Tefferi; Saubia Fathima; Maymona Abdelmagid; Ali Khalid A. Alsugair; Fnu Aperna; Mahsa Rezasoltani; Muhammad Yousuf; Anuya Natu; Clifford M. Csizmar; Mark Gurney; Terra L. Lasho; Christy M. Finke; Rashmi Kangal-Shamanna; Danielle Hammond; Kelly Chien; Alexandre Bazinet; Courtney D. DiNardo; Tapan M. Kadia; Abhishek A. Mangaonkar; Naval Daver; Animesh Pardanani; Gautam Borthakur; Cinthya Zepeda-Mendoza; Kaaren K. Reichard; Rong He; Sanam Loghavi; Francesco Passamonti; Farhad Ravandi; Koji Sasaki; Dirk R. Larson; Guillermo Garcia-Manero; Francesco Onida; Naseema Gangat; Guillermo Montalban-Bravo; Mrinal M. Patnaik
err分享
err收藏
Real-world treatment patterns and health outcomes for patients with myelofibrosis treated with fedratinib
errFUTURE ONCOLOGY
IF2.6
err2025-01-26
err0
errOAAI
errPassamonti, Francesco; Korgaonkar, Siddhi; Parikh, Rohan C.; Chevli, Manoj; Yucel, Aylin; Rombi, Julien; Jones, Shalon; Zissler, Dorothy; Davis, Keith L.; Slaff, Samantha
err分享
err收藏
POIESIS: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Phase 3 Study of Navtemadlin As Add-on to Ruxolitinib in JAK Inhibitor-Naive Patients with Myelofibrosis Who Have a Suboptimal Response to RuxolitinibPOIESIS：一项随机、双盲、安慰剂对照、多中心、全球性III期研究，评估纳特梅达林（Navtemadlin）作为鲁索利替尼（Ruxolitinib）加用疗法在鲁索利替尼无应答的骨髓纤维化患者中的疗效，该患者群体对鲁索利替尼反应欠佳。
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errVachhani, Pankit; Rampal, Raajit; Bradley, Terrence; Harrison, Claire; Jain, Tania; Kuykendall, Andrew T.; Palandri, Francesca; Mascarenhas, John O.; Al-Ali, Haifa Kathrin; Passamonti, Francesco; Nekhymchuk, Anna; Foss, Hilarie; Rothbaum, Wayne; Verstovsek, Srdan; Heidel, Florian
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
H
Hagop M. Kantarjian
H 指数: 230 · 论文数: 5.5K
E
Elı́as Campo
H 指数: 173 · 论文数: 1.6K
A
Ayalew Tefferi
H 指数: 152 · 论文数: 2.1K
P
Pierre Fenaux
H 指数: 130 · 论文数: 1.8K
A
Andreas Hochhaus
H 指数: 127 · 论文数: 1.6K
查看更多